Clinical Trial Results: Roferon-A [interferon alfa-2a]

Product Name: Roferon-A [interferon alfa-2a]
Date of Report: 3/31/2003
Phase: III
An open-label, multi-center, randomized, comparative clinical trial to evaluate the efficacy and safety of interferon alpha-2a (Roferon A injection) vs combination of oral amantadine (Viregyt K capsules) and interferon alpha-2a (Roferon A injection) in interferon- and amantadine-naïve patients with chronic hepatitis C.

Product Name: Roferon-A [interferon alfa-2a]
Date of Report: To be Published
Phase: IV
A Study of Roferon-A (interferon alfa-2a) in Patients with Chronic Hepatitis C